Trial Information

- A second course of induction chemotherapy can be given to the patient when a partial
remission but less than a complete remission is achieved after the first course. At
least 4 weeks should be apart between start of the first course and start of the second
course.

- G-CSF (Lenograstim) 250 g/day will begin to be administered after the confirmation of
hypocellular bone marrow with blasts less than 5% on day 14 or later until absolute
neutrophil counts are 1,000/l or more.

- For the patients who achieve a complete remission, consolidation therapy will be given
as follows:

- Two more cycles of the same chemotherapy will be given to the patients who achieve
a complete remission after single induction course. Allogeneic or autologous
hematopoietic cell transplantation could be also considered.

- In patients who relapse after allogeneic hematopoietic cell transplantation, donor
leukocyte infusion will be done without consolidation chemotherapy.

- In patients who had extramedullary relapse(s), local radiotherapy can be given to
the relapse site(s).